Supply of Radiopharmaceutical 177Lutetium - PSMA Dose 200 mCi

This tender is for the supply of a specific radiopharmaceutical: 177Lutetium - PSMA (Prostate-Specific Membrane Antigen) in a 200 millicurie (mCi) dose. This specialized medical product is used in targeted radionuclide therapy, particularly for the treatment of prostate cancer. The tender seeks a reliable supplier capable of providing high-quality, radiolabeled compounds that meet stringent pharmaceutical and regulatory standards. The procurement is essential for healthcare facilities offering advanced cancer treatments. The scope of supply will likely include not only the radiopharmaceutical itself but also potentially associated logistics, such as specialized packaging, transportation under controlled conditions (e.g., temperature, radiation shielding), and timely delivery to ensure its therapeutic efficacy. Bidders must demonstrate expertise in handling radioactive materials, adherence to Good Manufacturing Practices (GMP), and compliance with national and international regulations governing radiopharmaceuticals. The successful bidder will play a crucial role in enabling the provision of life-saving treatments to patients requiring PSMA-targeted radionuclide therapy.

This is a supplies contract in the health and medical services, transport and logistics and general supplies sectors, with a focus on General Supplies. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.